2024 World Immunodiagnostic Analyzers and Reagent Market Shares and Forecasts for Over 100 Tests: A 97-Country Survey--Growth Opportunities, Supplier Strategies, Emerging Technologies, Latest Instrumentation
This new 97-country report is available by region, country, market segment, section, or individual test.
The report is available by section, and can be customized to specific information needs and budget.
The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future market trends; forecasts specimen, test and sales volume; estimates sales and market shares of key suppliers in major countries; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers.
Clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
Asia-Pacific, Europe, Latin America, Middle East, North America
Albania, Argentina, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, El Salvador, Egypt, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Moldova, Morocco, Myanmar, Netherlands, New Zealand, Nicaragua, Nigeria, Norway, Oman, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, UK, Ukraine, United Arab Emirates, Uruguay, USA, Venezuela, Vietnam
Global Market Overview
- Estimates of facilities performing clinical chemistry and immunodiagnostic tests in major countries.
- Test volume and sales projections.
Market Segmentation Analysis
- Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers.
- Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays.
Individual Tests Analyzed in the Report
Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), Calcium, Carbon Dioxide/Bicarbonate, Cardio CRP, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Cystatin C, Ferritin, Fructosamine, GGT, Glucose, HDL Cholesterol, Homocysteine, hs-CRP, Insulin, Iron, Iron (Total Binding Capacity), Iron (Unsaturated Binding Capacity), LDH, LDL Cholesterol, LDL Cholesterol Direct, Lipase, Lipoprotein a, Magnesium, Microalbumin, NT-proBNP, Phosphorus, Potassium, Sodium, ST2, Total Protein, Triglycerides, Troponin, Uric Acid
Therapeutic Drug Monitoring (TDM)
Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin
Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Free, T3 Uptake, T4, T4 Free, TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH
Tumor Markers and Special Chemistry
AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12
C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, Protein Electrophoresis
Drugs of Abuse
Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants
Current and Emerging Products
- Analysis of current and emerging clinical chemistry and immunodiagnostic tests.
- Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.
- Assessment of current and emerging technologies, and their potential market applications.
- Companies developing or marketing new technologies and products by test.
- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
- The companies analyzed in the report include:
- Abbott Laboratories
- Agilent Technologies
- Beckman Coulter/Danaher
- Eiken Chemical
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- Ortho-Clinical Diagnostics
- Quest Diagnostics
- Siemens Healthineers
- Thermo Fisher
II. Worldwide Market Overview
A. Business Environment
B. Market Structure
C. Market Size and Growth
III. Major Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. Worldwide Market and Technology Overview
A. Major Routine Chemistry Tests
2. Alkaline Phosphatase
7. Bilirubin, Total
8. Blood Gases
9. Blood Urea Nitrogen (BUN)
12. Cardio CRP
a. Carbon Dioxide/Bicarbonate
20. Gamma-Glutamyl Transpeptidase (GGT)
22. High Density Lipoprotein (HDL)
26. Lactate Dehydrogenase (LDH)
33. Uric Acid
B. Therapeutic Drug Monitoring (TDM)
18. Valproic Acid
C. Endocrine Function Tests
3. Follicle-Stimulating Hormone (FSH)
5. Growth Hormone/IGF-1
6. Human Chorionic Gonadotropin (HCG)
9. PTH/IO PTH
12. T3 Free
13. T3 Uptake
14. T4 (Thyroxine)
15. T4 Free
18. Thyroglobulin Ab
19. TPO Ab
D. Tumor Markers and Special Chemistry Tests
2. CA 15-3
3. CA 19-9
4. CA 27-29
5. Carcinoembrionic Antigen (CEA)
6. Folate/Folic Acid
8. 25-Hydroxy Vitamin D2 and D3
9. Occult Blood
10. Prostate-Specific Antigen (PSA)
12. Vitamin B-12
E. Immunoprotein Tests
2. Free Light Chains
4. Immunoglobulins (IgA, IgE, IgG, IgM)
7. Protein Electrophoresis
F. Drugs of
2. Test Methodologies
8. Lysergic Acid Diethylamide (LSD)
13. Tricyclic Antidepressants
G. Clinical Chemistry and Immunodiagnostic Instrumentation
Review: Operating Characteristics and Features of High-,
H. Major Clinical Chemistry and Immunodiagnostic Technologies
And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
VIII. Country Market Analyses: Blood Typing, Grouping and Infectious Disease Screening Test
Volume and Sales Forecasts for 97 Countries:
Albania, Algeria, Argentina, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Brazil,
Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic,
Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Finland, France, Georgia,
Germany, Ghana, Greece, Guatemala, Haiti, Honduras, Hong Kong, Hungary, Iceland, India,
Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kuwait, Latvia,
Lebanon, Lithuania, Malaysia, Malta, Mexico, Moldova, Morocco, Myanmar, Netherlands, New
Zealand, Nicaragua, Nigeria, Norway, Oman, Pakistan, Panama, Paraguay, Peru, Philippines, Poland,
Portugal, Puerto Rico, Qatar, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovak Republic,
Slovenia, South Korea, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, UK, Ukraine,
United Arab Emirates, Uruguay, USA, Venezuela, Vietnam
2024 Europe Diagnostics Market Forecasts for 500 Tests: 38-Country Analysis--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM--Competitive Strategies, Opportunities for Suppliers
This new report provides granular analysis of the Europe diagnostic testing market, including: Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary,View Report
2024 LATAM 22-Country Diagnostics Market for 500 Tests: Blood Banking, Cancer, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM--Competition, Opportunities
This new report provides granular analysis of the Latin America diagnostic testing market, including:Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica,View Report
2024 World Nucleic Acid Testing (NAT) Analyzers and Reagent Market for 100 Assays: Americas, EMEA, APAC--A 68-Country Analysis--Supplier Shares by Test, Competitive Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review
This new 68-country survey provides granular data and analysis not available from any other source.The report is designed to help current suppliers and potential market entrants identify and evaluate majorView Report
2024 World Virology and Bacteriology Market for over 100 Tests: Americas, EMEA, APAC--A 68-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation, Opportunities
This unique 68-country survey provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well as companies planning toView Report
Fill The Form For Sample Request